Myelodysplastic syndrome: a review of 35 patients
Bursztyn, M.; Douer, D.; Ramot, B.
Israel Journal of Medical Sciences 23(11): 1140-1144
1987
ISSN/ISBN: 0021-2180 PMID: 3436796 Document Number: 291364
Thirty-five patients with myelodysplastic syndromes were retrospectively classified according to the FAB classification (French-American-British Cooperative Study Group). Their prognosis was found to be dependent mainly on the presence of blasts in bone marrow examination. Those with an excess of blasts in their bone marrow had a median survival of 30 months in contrast to 66 months in those without blasts. These results were compared with those of seven recent reported series.
Document emailed within 1 workday
Related Documents
Yanuck, M.D.; Saleem, A. 1991: Leukemic transformation in myelodysplastic syndrome: a review Annals of Clinical and Laboratory Science 21(3): 171-176Chen, P.H.; Kuo, C.Y.; Huang, C.H.; Shih, L.Y. 1992: Primary myelodysplastic syndrome: an analysis of 56 patients Changgeng Yi Xue Za Zhi 15(3): 121-127
Schrappe-Bächer, M.; Steffen, H.M.; Maier, M.; Bernards, P.; Hoeffken, A.; Fätkenheuer, G. 1990: Myelodysplastic syndrome--a retrospective study of 38 patients Medizinische Klinik 85(9): 511-516
Yu, Y.; Liu, X.-p.; Liu, S.-h.; Yu, M.-h.; Zhang, Y.; Xiao, Z.-j. 2007: Chromosomal structural changes in patients with myelodysplastic syndrome Zhonghua Yi Xue Za Zhi 87(38): 2693-2697
Jäger, G.; Höfler, G.; Linkesch, W.; Neumeister, P. 2004: Occurrence of a myelodysplastic syndrome (MDS) during first-line 2-chloro-deoxyadenosine (2-CDA) treatment of a low-grade gastrointestinal MALT lymphoma. Case report and review of the literature Haematologica 89(4): Ecr01
Marisavljević, D.; Rolović, Z. 1992: Immunomorphometric study of megakaryocytes in patients with myelodysplastic syndrome Srpski Arhiv Za Celokupno Lekarstvo 120(11-12): 317-320
Beran, M. 2000: Intensive chemotherapy for patients with high-risk myelodysplastic syndrome International Journal of Hematology 72(2): 139-150
Jelínek, J.; Neuwirt, J.; Neuwirtová, R. 1986: Clonal culture of hematopoietic cells in patients with the myelodysplastic syndrome Vnitrni Lekarstvi 32(3): 222-227
Sonoda, Y.; Okuda, T.; Yokota, S. 1989: Cytogenetic studies of hemopoietic colonies in patients with leukemia and myelodysplastic syndrome in vitro Rinsho Byori. Japanese Journal of Clinical Pathology Spec no 80: 198-208
Michalova, K.; Musilova, J.; Zemanova, Z. 1991: Consecutive chromosomal studies in patients with myelodysplastic syndrome (MDS). Czechoslovak MDS Cooperative Group Annales de Genetique 34(3-4): 212-218
Solé, F.; Pérez, A.; Woessner, S.; Olmedo, E.; Florensa, L.; Sans, J. 1991: Isochromosome 17q as the sole alteration in 2 patients with a myelodysplastic syndrome and its relation to myeloperoxidase activity Sangre 36(4): 323-325
Yoshida, M.; Tsunoda, S.; Akutsu, M.; Furukawa, Y.; Takeda, K.; Akashi, M.; Komatsu, N.; Muroi, K.; Ikeda, K.; Ohsaka, A. 1987: The clinical effect of low-dose Ara-C in patients with refractory acute nonlymphocytic leukemia and myelodysplastic syndrome Gan to Kagaku Ryoho. Cancer and ChemoTherapy 14(4): 1057-1062
Tan, L.J.; Pang, G.Y.; Hong, W.D. 1993: Research on the activity and quantity of natural killer cells and T lymphocytes in myelodysplastic syndrome patients Zhonghua Nei Ke Za Zhi 32(5): 319-321
Tong, H.-y.; Hu, C.; Yu, M.-x.; Ma, Q.-l.; Chen, F.-f.; Ye, L.; Wei, J.-y.; Xu, G.-x.; Mao, L.-p.; Li, Y.; Jin, J. 2013: Relationship between clinical characteristics and myelodysplastic syndrome patients with isocitrate dehydrogenase gene mutations Zhonghua Yi Xue Za Zhi 93(40): 3180-3184
Fang, B.-z.; Liu, Z.-z.; He, G.-s.; Miao, M.; Wang, X.-L.; Qiu, H.-y.; Jin, Z.-m.; Tang, X.-w.; Han, Y.; Fu, Z.-z.; Ma, X.; Sun, A.-n.; Wu, D.-p.; Ruan, C.-g. 2013: Lower risk myelodysplastic syndrome patients with transfusion dependent treated by dose-reduced decitabine Zhonghua Yi Xue Za Zhi 93(40): 3189-3192
Qian, J.; Chen, Z.-x.; Wang, W.; Cen, J.-n.; Xue, Y.-q. 2004: Transcriptome profiling of marrow mononuclear cells of patients with myelodysplastic syndrome using cDNA microarray analysis Zhonghua Yi Xue Za Zhi 84(15): 1260-1264
Ueda, T.; Tohyama, K.; Wano, Y.; Tsutani, H.; Fukushima, T.; Iwasaki, H.; Urasaki, Y.; Gotoh, N.; Kimura, S.; Okumura, E. 1994: Pharmacokinetic and clinical pilot study of high-dose intermittent ubenimex treatment in patients with myelodysplastic syndrome Anticancer Research 14(5b): 2093-2097
Tsuchida, T.; Sakane, T.; Ishikura, H.; Tsunematsu, T. 1991: Impairment of lymphocyte function in patients with myelodysplastic syndrome and its correction by addition of Ca2+ ionophore and phorbol myristate acetate International Journal of Hematology 54(6): 505-513
Shen, Y.; Xue, Y.; Li, J.; Pan, J.; Wu, Y. 2003: Clinical, cytogenetic and dual-color FISH studies on five cases of myelodysplastic syndrome or acute myeloid leukemia patients with 1;7 translocation Chinese Medical Journal 116(2): 231-234
Ducastelle, S.; Adès, L.; Gardin, C.; Dombret, Hé.; Prébet, T.; Deconinck, E.; Rio, B.; Thomas, X.; Debotton, S.; Guerci, Aès.; Gratecos, N.; Stamatoullas, A.; Fegueux, N.; Dreyfus, Fçois.; Fenaux, P.; Wattel, E. 2006: Long-term follow-up of autologous stem cell transplantation after intensive chemotherapy in patients with myelodysplastic syndrome or secondary acute myeloid leukemia Haematologica 91(3): 373-376